Tralokinumab: all 31 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
• A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic TherapyCompletedNCT05958407Phase 3Results posted
• Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)CompletedNCT05194540Phase 3Results posted
• Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic DermatitisCompletedNCT04587453Phase 3Results posted
• Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7CompletedNCT03761537Phase 3Results posted
• Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTENDCompletedNCT03587805Phase 3Results posted
• Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)CompletedNCT03562377Phase 2Results posted
• Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).CompletedNCT03526861Phase 3Results posted
• Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3CompletedNCT03363854Phase 3Results posted
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)CompletedNCT03160885Phase 3Results posted
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)CompletedNCT03131648Phase 3Results posted
• A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled AsthmaTerminatedNCT02902809Phase 3Results posted
• A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia AreataCompletedNCT02684097Phase 2Results posted
• Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on CorticosteroidsCompletedNCT02449473Phase 2Results posted
• Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent AsthmaCompletedNCT02281357Phase 3Results posted
• A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled AsthmaCompletedNCT02194699Phase 3Results posted
• A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled AsthmaCompletedNCT02161757Phase 3Results posted
• A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy VolunteersCompletedNCT02085473Phase 1Results posted
• A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary FibrosisTerminatedNCT01629667Phase 2Results posted
• A Phase 1, Open-label Study to Investigate the Pharmacokinetics of Tralokinumab (CAT-354) in Adolescents With AsthmaCompletedNCT01592396Phase 1Results posted
• Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative ColitisCompletedNCT01482884Phase 2Results posted
• A Safety and Efficacy Study of Tralokinumab in Adults With AsthmaCompletedNCT01402986Phase 2Results posted
• A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate AsthmaTerminatedNCT00974675Phase 1Results posted
• Study to Evaluate the Safety and Efficacy of CAT-354CompletedNCT00873860Phase 2Results posted
• A Study to Assess the Efficacy, Safety, and Tolerability of CAT-354 in Subjects With AsthmaTerminatedNCT00640016Phase 2Results posted
• A Study to Assess Bioavailability and Pharmacokinetics of CAT- 354CompletedNCT00638989Phase 1Results posted
• Tralokinumab for Dupilumab FailuresTerminatedNCT06773455Phase 4
• Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)CompletedNCT05388760Phase 2
• Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier FunctionCompletedNCT04556461Phase 2
• Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4CompletedNCT03556592Phase 1
• A Study to Assess the Safety and Immunogenicity of the Drug CAT-354 in Healthy Japanese SubjectsCompletedNCT01093040Phase 1

← Tralokinumab overview